Advanced Management Strategies for Hidradenitis Suppurativa: Management of Early HS

The presentation focuses on advanced management strategies for early Hidradenitis Suppurativa (HS), emphasizing the importance of understanding the disease at its mild stages. The speaker, Hal Flowers, outlines the need to accurately assess disease severity, establish strong doctor-patient relationships, and explore various treatment options that include topical therapies, lifestyle modifications, hormones, and small molecules, while drawing parallels with acne. He discusses a hypothetical case of a 32-year-old female patient with mild HS symptoms, stressing that treatment begins with evaluating pain, flare frequency, and the disease's impact on the patient. Recommended lifestyle changes such as weight loss and smoking cessation must be approached sensitively, to avoid further stigmatization of patients.



Topical treatments like Clindamycin and Resorcinol, along with laser hair removal, are highlighted as effective options for early HS. The presentation further notes the role of oral antibiotics and hormonal treatments, particularly for patients experiencing menstrual flares, where medications like oral contraceptives and Spironolactone may be beneficial. Lastly, the potential of phosphodiesterase-4 inhibitors is discussed, with a hopeful outlook for future approvals in HS management. Overall, this presentation underscores the necessity for tailored, compassionate care in the early stages of HS, aiming to prevent the disease's progression and improve patient quality of life.